COVER STORY: Global Biotech Report
Buisness Facilities Contributed Content
APRIL 22, 2013
A retreat in the public markets in 2011 resulted in overall financing levels that are back to those seen in 2008, reflecting the continuing struggles of the Eurozone countries over the sovereign debt of some member countries. Across Europe, there were 56 venture rounds of greater than $5 million (down from 65 in 2010).
Let's personalize your content